SJ

Srinivasarao Jonnalagadda

Active Director Director DIN 11442991
DIN 11442991 First appointment Dec 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Srinivasarao Jonnalagadda

Data last updated:

Srinivasarao Jonnalagadda is a Director at Ingen Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11442991
Primary Designation Director
Industry Pharma
First Appointment 22 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Dec 20252025Active

Board colleagues of Srinivasarao Jonnalagadda

NameDINCompanyDesignation
Bhavani Pasupuleti11442992Ingen Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ingen Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Srinivasarao Jonnalagadda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivasarao Jonnalagadda

Srinivasarao Jonnalagadda currently holds 1 directorship: Ingen Pharmaceuticals Private Limited (Director, since 22 Dec 2025).

Srinivasarao Jonnalagadda was first appointed on 22 Dec 2025 as Director at Ingen Pharmaceuticals Private Limited.

The current boards of Srinivasarao Jonnalagadda's companies include Bhavani Pasupuleti (Ingen Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available